Exchange: NSE·Updated 10:31 AM GMT+5:30

MANKIND.NSE News

News
all
press releases
Mankind Pharma Strengthens Specialty Segment With ₹797 Crore BSV Deal
The analyst cautioned that smooth integration and execution over the next year will be key to unlocking its full value.
Stocktwits
Mankind Pharma Strengthens Specialty Segment With ₹797 Crore BSV Deal
The analyst cautioned that smooth integration and execution over the next year will be key to unlocking its full value.
Stocktwits
More News
Tata Capital to list on NSE and BSE today. The grey market premium suggests a lacklustre debut for India’s largest IPO
Stocktwits
GNFC, Mankind Pharma, Waaree Energies, and three other stocks are trending on analysts’ radar.
Stocktwits
ABB India, ITC, Adani Power, and Federal Bank are among the companies reporting quarterly results later in the day.
Stocktwits
The analyst identifies strong setups in L&T Finance, IDFC First Bank, and Eternal, while maintaining caution on names such as Vodafone Idea.
Stocktwits
Mankind Pharma, Danish Power and Everest Kanto have seen heavy selling pressure in 2025, but technical indicators signal bearish exhaustion
Stocktwits

Advertisement|Remove ads.